Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • johneazevedo johneazevedo Feb 24, 2012 1:11 PM Flag

    Dual Inhibition of MET and VEGF Signaling With Cabozantinib Blocks Tumor Invasiveness and Metastasis

    you said it. this stock isn't going anywhere. Tularik hit the $70/$80 before being purchased by Amgen with a lot less going for it. If it's going no place now, it's going no place later

 
EXEL
3.08-0.02(-0.65%)Apr 24 4:00 PMEDT